Media-OutReach Newswire The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist
Hosting P4G summit reflects Việt Nam’s growing leadership in advancing global green growth efforts 4.